Non-Coding RNAs Are Implicit in Chronic Myeloid Leukemia Therapy Resistance

Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm initiated by the presence of the fusion gene BCR::ABL1. The development of tyrosine kinase inhibitors (TKIs) highly specific to p210(BCR)(-ABL1), the constitutively active tyrosine kinase encoded by BCR::ABL1, has greatly improved the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Rudich, Alexander, Garzon, Ramiro, Dorrance, Adrienne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603161/
https://www.ncbi.nlm.nih.gov/pubmed/36293127
http://dx.doi.org/10.3390/ijms232012271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603161/
https://www.ncbi.nlm.nih.gov/pubmed/36293127
http://dx.doi.org/10.3390/ijms232012271

Ejemplares similares